Literature DB >> 12431306

Computer-based analysis of dynamic QT changes: toward high precision and individual rate correction.

Corina Dota1, Bo Skallefell, Nils Edvardsson, Gunnar Fager.   

Abstract

BACKGROUND: New strategies are needed to improve the results of automatic measurement of the various parts of the ECG signal and their dynamic changes.
METHODS: The EClysis software processes digitally-recorded ECGs from up to 12 leads at 500 Hz, using strictly defined algorithms to detect the PQRSTU points and to measure ECG intervals and amplitudes. Calculations are made on the averaged curve of each sampling period (beat group) or as means +/- SD for beat groups, after being analyzed at the individual beat level in each lead. Resulting data sets can be exported for further statistical analyses. Using QT and R-R measured on beat level, an individual correction for the R-R dependence can be performed.
RESULTS: EClysis assigns PQRSTU points and intervals in a sensitive and highly reproducible manner, with coefficients of variation in ECG intervals corresponding to ca. 2 ms in the simulated ECG. In the normal ECG, the CVs are 2% for QRS, 0.8% for QT, and almost 6% for PQ intervals. EClysis highlights the increase in QT intervals and the decrease of T-wave amplitudes during almokalant infusion versus placebo. Using the observed linear or exponential relationships to adjust QT for R-R dependence in healthy subjects, one can eliminate this dependence almost completely by individualized correction.
CONCLUSIONS: The EClysis system provides a precise and reproducible method to analyze ECGs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431306      PMCID: PMC7027718          DOI: 10.1111/j.1542-474x.2002.tb00177.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  29 in total

Review 1.  Controlling cardiac arrhythmias by lengthening repolarization: rationale from experimental findings and clinical considerations.

Authors:  B N Singh; J S Sarma; Z H Zhang; C Takanaka
Journal:  Ann N Y Acad Sci       Date:  1992-01-27       Impact factor: 5.691

2.  Common standards for quantitative electrocardiography: goals and main results. CSE Working Party.

Authors:  J L Willems; P Arnaud; J H van Bemmel; R Degani; P W Macfarlane; C Zywietz
Journal:  Methods Inf Med       Date:  1990-09       Impact factor: 2.176

3.  Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion.

Authors:  I Savelieva; G Yi; X Guo; K Hnatkova; M Malik
Journal:  Am J Cardiol       Date:  1998-02-15       Impact factor: 2.778

Review 4.  Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias.

Authors:  I Cavero; M Mestre; J M Guillon; W Crumb
Journal:  Expert Opin Pharmacother       Date:  2000-07       Impact factor: 3.889

5.  Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.

Authors:  B Houltz; B Darpö; N Edvardsson; P Blomström; J Brachmann; H J Crijns; S M Jensen; E Svernhage; H Vallin; K Swedberg
Journal:  Pacing Clin Electrophysiol       Date:  1998-05       Impact factor: 1.976

Review 6.  CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

Authors:  M Akhtar; G Breithardt; A J Camm; P Coumel; M J Janse; R Lazzara; R J Myerburg; P J Schwartz; A L Waldo; H J Wellens
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

7.  Errors in manual measurement of QT intervals.

Authors:  A Murray; N B McLaughlin; J P Bourke; J C Doig; S S Furniss; R W Campbell
Journal:  Br Heart J       Date:  1994-04

8.  A PC-based on-line system for physiological in vivo and in vitro experiments.

Authors:  J E Axenborg; I Hirsch
Journal:  Comput Methods Programs Biomed       Date:  1993-09       Impact factor: 5.428

9.  Human precision of operating a digitizing board: implications for electrocardiogram measurements.

Authors:  M Malik; A Bradford
Journal:  Pacing Clin Electrophysiol       Date:  1998-08       Impact factor: 1.976

10.  QT interval measurement by a computer assisted program: a potentially useful clinical parameter.

Authors:  P E Puddu; P M Bernard; B R Chaitman; M G Bourassa
Journal:  J Electrocardiol       Date:  1982-01       Impact factor: 1.438

View more
  6 in total

1.  Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.

Authors:  Nkechi E Azie; Gregory Adams; Borje Darpo; Steven F Francom; Emery C Polasek; Joy M Wisser; Joseph C Fleishaker
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

2.  PC-Based ECG waveform recognition-validation of novel software against a reference ECG database.

Authors:  Corina-Dana Dota; Nils Edvardsson; Bo Skallefell; Gunnar Fager
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

3.  Comparing QT interval variability of semiautomated and high-precision ECG methodologies in seven thorough QT studies-implications for the power of studies intended for definitive evaluation of a drug's QT effect.

Authors:  Karin Meiser; Pierre Jordaan; Sasha Latypova; Borje Darpo
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-12-19       Impact factor: 1.468

4.  Assessment of ventricular repolarization variability with the DeltaT50 method improves identification of patients with congenital long QT syndromes.

Authors:  Christina Abrahamsson; Corina Dota; Bo Skallefell; Leif Carlsson; Lars Frison; Anders Berggren; Nils Edvardsson; Göran Duker
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

Review 5.  Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective.

Authors:  C E Pollard; J-P Valentin; T G Hammond
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

6.  Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study.

Authors:  Glenn F Carlson; Conrad K P Tou; Shamik Parikh; Bruce K Birmingham; Kathleen Butler
Journal:  Diabetes Ther       Date:  2011-06-24       Impact factor: 2.945

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.